Research study of an investigational medication or placebo taken twice daily in subjects with Alzheimer’s Type Dementia and agitation. Up to 10 weeks (7 visits). We are conducting an 18-month research study of an investigational medication vs. placebo (an inactive substance) for Early Alzheimer’s Disease.
At Risk for Alzheimer’s Disease Study
At Risk for Alzheimer’s Disease Study
We have helped tens of thousands of patients in similar studies.
Space in this study is limited. To be considered, please fill out the form or call 818-990-2671.
No cost studies are currently available for qualified participants.
No health insurance required
Compensation for time and travel up to $5,500
Compensation: Up to $100/visit
Male / Female
60-80 years old
4835 Van Nuys Blvd., Suite 104
Sherman Oaks, CA 91403
CNR is California's premier clinical research organization. For over 20 years, we’ve helped improve the quality of life for everyone by researching new medications and treatments. Our facility is held to the highest standards of cleanliness and quality.
Your safety is our greatest concern. Every study at CenExel CNR is overseen by expert medical staff and one of the most well-respected, board-certified physicians in the clinical research industry with 25+ years of experience.
Rest assured, you are not signing up for treatment with “experimental” methods. CenExel CNR only uses FDA approved methods as if you were at any other hospital or clinic. Our research is focused on the medication associated with those methods.
Frequently asked questions
What is a CenExel Center of Excellence?
CenExel Centers of Excellence provide unparalleled medical and scientific support in the design and execution of clinical trials. Their attention to detail assures quality, reliable results and has helped CenExel to consistently achieve and exceed patient recruitment goals. They have conducted thousands of studies, the variety and complexity of which have resulted in a great depth of experience and insight for the principal investigators and research staff in each facility. CenExel Centers of Excellence deliver the engagement, expertise, and results to ensure that clients achieve their clinical research goals.
How do clinical trials work?
The study procedures and process will vary depending on the type of clinical trial you participate in. Before you begin a study, the process and all procedures for that study will be explained to you. Throughout the study, the Study Coordinator and the Principal Investigator will assist you and can answer any questions you have. They will check your health at the beginning of the trial, give you specific instructions for participating in the trial, monitor you carefully during the trial, and stay in touch with you after the study.
Some clinical trials involve more tests and doctor visits than you would normally have for your illness or condition. Your participation will be most successful if you carefully follow all instructions you are given and stay in contact with the research staff.
How safe are clinical studies?
There are many safeguards in place that all companies must follow when conducting clinical trials.
The Food and Drug Administration (FDA) is the regulatory agency that oversees all clinical research conducted in the United States. It is their responsible to protect the rights and as much as possible, the welfare of subjects participating in clinical trials. They ensure that data collected from clinical trials is of the highest quality and they are the agency that determines whether a new treatment should be sold in the US. Several organizations and individuals are governed by FDA regulations including clinical investigators, sponsors (the companies developing the treatments), Contract Research Organizations (companies that help conduct the studies), and Institutional Review Boards (groups that are responsible for ensuring the safety and welfare of study participants).
Good Clinical Practice (GCP) guidelines are another safeguard implemented to protect the safety of subjects. These guidelines encompass federal regulations and industry-accepted standards that govern clinical trials on humans. These regulations and standards apply to the conduct of the studies, record keeping, informed consent of subjects, collection of scientific data, and submission of information needed for the FDA to determine whether a new treatment should or should not be sold in the US. All companies must follow these guidelines when conducting clinical research.
An Institutional Review Board (IRB) is a committee that is formally tasked by an institution to review, approve, and monitor research involving human subjects. IRBs ensure that the risks to subjects are minimized; that subjects are adequately informed about the trial and the implications it will have on their treatment; that study protocols are modified, when necessary, to ensure safety; that risks are reasonable in relation to the anticipated benefits and the importance of the knowledge to be gained; that subject selection is equitable and that no classes of patients are discriminated against; that informed consent is obtained; that there is a provision for safety monitoring in the research plan; and that here are adequate provisions for the privacy and confidentiality for subjects and the data collected.